Goldman Sachs Group Inc Galapagos Nv Put Options Transaction History

Goldman Sachs Group Inc

  • $605 Billion
  • Q3 2024

Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2022

May 14, 2024
BUY
$42.27 - $57.6 $1.06 Million - $1.44 Million
25,000 New
25,000 $1.07 Million
Q3 2022

Nov 10, 2022
BUY
$42.27 - $57.6 $1.06 Million - $1.44 Million
25,000 New
25,000 $1.07 Million
Q4 2021

Feb 14, 2022
SELL
$47.03 - $57.12 $112,872 - $137,088
-2,400 Reduced 9.64%
22,500 $1.24 Million
Q3 2021

Nov 10, 2021
BUY
$52.17 - $70.2 $1.3 Million - $1.75 Million
24,900 New
24,900 $1.31 Million

Others Institutions Holding GLPG

# of Institutions
85
Shares Held
12.3M
Call Options Held
69.1K
Put Options Held
42.7K
View Full List

About GALAPAGOS NV

GLPG Quotes by TradingView
  • Ticker GLPG
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,835,500
  • Market Cap $1.9B
  • Description
  • Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...
More about GLPG
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email